a, Comparison of mouse Foxp3 genomic sequence to human, dog and rat. b–e, Map of permissive chromatin modifications at the Foxp3 locus by ChIP–qPCR with primers spaced at ∼1-kb intervals for B220+ B cells (B), CD4+CD25− TN cells, and CD4+CD25+ Treg (TR) cells. Relative (rel.) enrichment data are shown for H3K9/14Ac (b), H3K4me3 (c), H3K4me2 (d) and H3K4me1 (e). f, H3K4me1 ChIP–qPCR as in e, for CD4+CD8+ (double positive, DP) and CD4+CD8− (CD4 single positive, CD4SP) thymocytes, and Treg cells. In b–f, green bars denote the promoter (Pro) and CNS1–3. g, NF-κB consensus motif in CNS3 (core motif in bold) and homologous CD28RE motifs from Il2 and Fas. N, any base; R, purine; Y, pyrimidine. h, Binding of NF-κB family member c-Rel but not p65 to the CD28RE-like element at CNS3. Nuclear lysates from unstimulated or stimulated (1 μg ml−1 CD3 and CD28 antibodies, 2 ng ml−1 TGF-β) TN cells were incubated with biotinylated double-stranded (ds)DNA probes containing the full-length CNS3 sequence (CNS3 WT), the full-length CNS3 sequence with the mutated core c-Rel motif (CNS3 Δc-Rel), the core CNS3 c-Rel motif, Il2 CD28RE (positive control), and Il2 ΔCD28RE (negative control). dsDNA probes and bound protein were precipitated by streptavidin beads and subjected to c-Rel and p65 western blot analysis.